Search Results - "Cao, Ka‐Jia"

Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma by Tang, Lin-Quan, Li, Chao-Feng, Li, Jing, Chen, Wen-Hui, Chen, Qiu-Yan, Yuan, Lian-Xiong, Lai, Xiao-Ping, He, Yun, Xu, Yun-Xiu-Xiu, Hu, Dong-Peng, Wen, Shi-Hua, Peng, Yu-Tuan, Zhang, Lu, Guo, Shan-Shan, Liu, Li-Ting, Guo, Ling, Wu, Yi-Shan, Luo, Dong-Hua, Huang, Pei-Yu, Mo, Hao-Yuan, Xiang, Yan-Qun, Sun, Rui, Chen, Ming-Yuan, Hua, Yi-Jun, Lv, Xing, Wang, Lin, Zhao, Chong, Cao, Ka-Jia, Qian, Chao-Nan, Guo, Xiang, Zeng, Yi-Xin, Mai, Hai-Qiang, Zeng, Mu-Sheng

“…This study aimed to establish an effective prognostic nomogram with or without plasma Epstein-Barr virus DNA (EBV DNA) for nondisseminated nasopharyngeal…”
Get full text

Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial by Tang, Lin-Quan, Chen, Dong-Ping, Guo, Ling, Mo, Hao-Yuan, Huang, Ying, Guo, Shan-Shan, Qi, Bin, Tang, Qing-Nan, Wang, Pan, Li, Xiao-Yun, Li, Ji-Bin, Liu, Qing, Gao, Yuan-Hong, Xie, Fang-Yun, Liu, Li-Ting, Li, Yang, Liu, Sai-Lan, Xie, Hao-Jun, Liang, Yu-Jing, Sun, Xue-Song, Yan, Jin-Jie, Wu, Yi-Shan, Luo, Dong-Hua, Huang, Pei-Yu, Xiang, Yan-Qun, Sun, Rui, Chen, Ming-Yuan, Lv, Xing, Wang, Lin, Xia, Wei-Xiong, Zhao, Chong, Cao, Ka-Jia, Qian, Chao-Nan, Guo, Xiang, Hong, Ming-Huang, Nie, Zhi-Qiang, Chen, Qiu-Yan, Mai, Hai-Qiang

“…Cisplatin-based concurrent chemoradiotherapy is currently considered to be the standard treatment regimen for patients with advanced nasopharyngeal carcinoma,…”
Get full text

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial by Lv, Xing, Cao, Xun, Xia, Wei-Xiong, Liu, Kui-Yuan, Qiang, Meng-Yun, Guo, Ling, Qian, Chao-Nan, Cao, Ka-Jia, Mo, Hao-Yuan, Li, Xian-Ming, Li, Zi-Huang, Han, Fei, He, Yu-Xiang, Liu, Yu-Meng, Wu, Shao-Xiong, Bai, Yong-Rui, Ke, Liang-Ru, Qiu, Wen-Ze, Liang, Hu, Liu, Guo-Ying, Miao, Jing-Jing, Li, Wang-Zhong, Lv, Shu-Hui, Chen, Xi, Zhao, Chong, Xiang, Yan-Qun, Guo, Xiang

“…Cisplatin-based induction chemotherapy plus concurrent chemoradiotherapy in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma has…”
Get full text

Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial by CHEN, Qiu-Yan, WEN, Yue-Feng, RUI SUN, DENG, Man-Quan, CHEN, Ming-Yuan, HUA, Yi-Jun, XIANG GUO, CAO, Ka-Jia, HONG, Ming-Huang, QIAN, Chao-Nan, MAI, Hai-Qiang, LING GUO, HUAI LIU, HUANG, Pei-Yu, MO, Hao-Yuan, LI, Ning-Wei, XIANG, Yan-Qun, LUO, Dong-Hua, FANG QIU

“…Concurrent chemoradiotherapy (CCRT) has been shown to improve outcomes for stage III-IV nasopharyngeal carcinoma (NPC) patients compared with radiotherapy (RT)…”
Get full text

The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma by Liu, Li-Ting, MD, Tang, Lin-Quan, MD, PhD, Chen, Qiu-Yan, MD, PhD, Zhang, Lu, MD, Guo, Shan-Shan, MD, Guo, Ling, MD, PhD, Mo, Hao-Yuan, MD, PhD, Zhao, Chong, MD, PhD, Guo, Xiang, MD, PhD, Cao, Ka-Jia, MD, PhD, Qian, Chao-Nan, MD, PhD, Zeng, Mu-Sheng, MD, PhD, Bei, Jin-Xin, MD, PhD, Hong, Ming-Huang, MD, PhD, Shao, Jian-Yong, MD, PhD, Sun, Ying, MD, PhD, Ma, Jun, MD, PhD, Mai, Hai-Qiang, MD, PhD

“…Purpose To explore the prognostic value of the plasma load of Epstein-Barr viral (EBV) DNA and the tumor response to neoadjuvant chemotherapy (NACT) in…”
Get full text

Prospective Study of Tailoring Whole-Body Dual-Modality [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography With Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging by TANG, Lin-Quan, CHEN, Qiu-Yan, MO, Yun-Xian, LIU, Li-Zhi, MO, Hao-Yuan, JIAN LI, ZOU, Ru-Hai, YUN CAO, XIANG, Yan-Qun, FANG QIU, RUI SUN, CHEN, Ming-Yuan, WEI FAN, HUA, Yi-Jun, XING LV, LIN WANG, CHONG ZHAO, XIANG GUO, CAO, Ka-Jia, QIAN, Chao-Nan, ZENG, Mu-Sheng, MAI, Hai-Qiang, HUAI LIU, LU ZHANG, LING GUO, LUO, Dong-Hua, HUANG, Pei-Yu, XU ZHANG, LIN, Xiao-Ping

“…To evaluate which patients with nasopharyngeal carcinoma (NPC) obtained the greatest benefits from the detection of distant metastasis with…”
Get full text

Cetuximab or nimotuzumab plus intensity‐modulated radiotherapy versus cisplatin plus intensity‐modulated radiotherapy for stage II‐IVb nasopharyngeal carcinoma by You, Rui, Sun, Rui, Hua, Yi‐Jun, Li, Chao‐Feng, Li, Ji‐Bin, Zou, Xiong, Yang, Qi, Liu, You‐Ping, Zhang, Yi‐Nuan, Yu, Tao, Cao, Jing‐Yu, Zhang, Meng‐Xia, Jiang, Rou, Mo, Hao‐Yuan, Guo, Ling, Cao, Ka‐Jia, Lin, Ai‐Hua, Qian, Chao‐Nan, Sun, Ying, Ma, Jun, Chen, Ming‐Yuan

“…To compare intensity‐modulated radiotherapy (IMRT) with cisplatin (CDDP) versus cetuximab (CTX) and nimotuzumab (NTZ) for Stage II‐IVb Nasopharyngeal Carcinoma…”
Get full text

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma： a retrospective controlled study by Qiu, Wen-Ze, Huang, Pei-Yu, Shi, Jun-Li, Xia, Hai-Qun, Zhao, Chong, Cao, Ka-Jia

“…Background： In the era of intensity-modulated radiotherapy （IMRT）, the role of neoadjuvant chemotherapy （NAC） for Iocoregionally advanced nasopharyngeal…”
Get full text

Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case-control study by Li, Yang, Chen, Qiu-Yan, Tang, Lin-Quan, Liu, Li-Ting, Guo, Shan-Shan, Guo, Ling, Mo, Hao-Yuan, Chen, Ming-Yuan, Guo, Xiang, Cao, Ka-Jia, Qian, Chao-Nan, Zeng, Mu-Shen, Bei, Jin-Xin, Shao, Jian-Yong, Sun, Ying, Tan, Jing, Chen, Shuai, Ma, Jun, Zhao, Chong, Mai, Hai-Qiang

“…This study aimed to evaluate the long-term outcome and toxicities in patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by concurrent…”
Get full text

Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology? by Guo, Shan-Shan, Tang, Lin-Quan, Chen, Qiu-Yan, Zhang, Lu, Liu, Li-Ting, Huang, Pei-Yu, Cao, Ka-Jia, Guo, Ling, Mo, Hao-Yuan, Guo, Xiang, Hong, Ming-Huang, Zeng, Mu-Sheng, Qian, Chao-Nan, Mai, Hai-Qiang

“…Hemoglobin (Hb) levels are regarded as an important determinant of outcome in a number of cancers treated with radiotherapy. However, for patients treated with…”
Get full text

Use of a posterior pedicle nasal septum and floor mucoperiosteum flap to resurface the nasopharynx after endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma by Chen, Ming-Yuan, Wang, Shun-Lan, Zhu, Yu-Liang, Shen, Guo-Ping, Qiu, Fang, Luo, Dong-Hua, Chen, Qiu-Yan, Jiang, Rou, Cao, Ka-Jia, Qian, Chao-Nan, Hong, Ming-Huang

“…Background Endoscopic nasopharyngectomy is a new salvage treatment for locally recurrent nasopharyngeal carcinoma (NPC). However, how to resurface the…”
Get full text

Type 2 Diabetic Mellitus Is a Risk Factor for Nasopharyngeal Carcinoma: A 1:2 Matched Case-Control Study by Peng, Xing-Si, Xie, Guo-Feng, Qiu, Wen-Ze, Tian, Yun-Hong, Zhang, Wei-Jun, Cao, Ka-Jia

“…Diabetes has been identified as an adverse prognostic variable which associated with an increased mortality in various cancers, including colorectal, lung, and…”
Get full text

High-Sensitivity C-Reactive Protein Complements Plasma Epstein-Barr Virus Deoxyribonucleic Acid Prognostication in Nasopharyngeal Carcinoma: A Large-Scale Retrospective and Prospective Cohort Study by Tang, Lin-Quan, MD, PhD, Li, Chao-Feng, PhD, Chen, Qiu-Yan, MD, PhD, Zhang, Lu, MD, Lai, Xiao-Ping, MD, He, Yun, MD, Xu, Yun-Xiu-Xiu, MD, Hu, Dong-Peng, MD, Wen, Shi-Hua, MD, Peng, Yu-Tuan, MD, Chen, Wen-Hui, MD, PhD, Liu, Huai, MD, PhD, Guo, Shan-Shan, MD, Liu, Li-Ting, MD, Li, Jing, MD, PhD, Zhang, Jing-Ping, MD, PhD, Guo, Ling, MD, PhD, Zhao, Chong, MD, PhD, Cao, Ka-Jia, MD, PhD, Qian, Chao-Nan, MD, PhD, Zeng, Yi-Xin, MD, PhD, Guo, Xiang, MD, Mai, Hai-Qiang, MD, PhD, Zeng, Mu-Sheng, MD, PhD

“…Purpose To evaluate the effects of combining the assessment of circulating high-sensitivity C-reactive protein (hs-CRP) with that of Epstein-Barr virus DNA…”
Get full text

Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT by Guo, Shan-Shan, Hu, Wen, Chen, Qiu-Yan, Li, Jian-Mei, Zhu, Shi-Heng, He, Yan, Li, Jia-Wen, Xia, Le, Ji, Lu, Lin, Cui-Ying, Liu, Li-Ting, Tang, Lin-Quan, Guo, Ling, Mo, Hao-Yuan, Zhao, Chong, Guo, Xiang, Cao, Ka-Jia, Qian, Chao-Nan, Zeng, Mu-Sheng, Hong, Ming-Huang, Shao, Jian-Yong, Sun, Ying, Ma, Jun, Fan, Yu-Ying, Mai, Hai-Qiang

“…To evaluate the prognostic significance of pretreatment quality of life for patients with nasopharyngeal carcinoma treated with intensity-modulated…”
Get full text

The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapy by Xia, Wei-Xiong, Ye, Yan-Fang, Lu, Xing, Wang, Lin, Ke, Liang-Ru, Zhang, Hai-Bo, Roycik, Mark D, Yang, Jing, Shi, Jun-Li, Cao, Ka-Jia, Guo, Xiang, Xiang, Yan-Qun

“…The aim of this study was to determine whether baseline C-reactive protein (CRP) levels and CRP kinetics predict the overall survival in metastatic…”
Get full text

Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy by Liu, Huai, Qi, Bin, Guo, Xiang, Tang, Lin-Quan, Chen, Qiu-Yan, Zhang, Lu, Guo, Ling, Luo, Dong-Hua, Huang, Pei-Yu, Mo, Hao-Yuan, Xiang, Yan-Qun, Qiu, Fang, Sun, Rui, Zhang, Ying, Chen, Ming-Yuan, Hua, Yi-Jun, Lv, Xing, Wang, Lin, Zhao, Chong, Cao, Ka-Jia, Qian, Chao-Nan, Hong, Ming-Huang, Mai, Hai-Qiang

“…Treatment outcomes vary greatly in patients with nasopharyngeal carcinoma (NPC). The purpose of this study is to evaluate the influence of radiation and…”
Get full text

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial by Yang, Qi, Cao, Su-Mei, Guo, Ling, Hua, Yi-Jun, Huang, Pei-Yu, Zhang, Xiao-Long, Lin, Mei, You, Rui, Zou, Xiong, Liu, You-Ping, Xie, Yu-Long, Wang, Zhi-Qiang, Mai, Hai-Qiang, Chen, Qiu-Yan, Tang, Lin-Quan, Mo, Hao-Yuan, Cao, Ka-Jia, Qian, Chao-Nan, Zhao, Chong, Xiang, Yan-Qun, Zhang, Xiu-Ping, Lin, Zhi-Xiong, Li, Wei-Xiong, Liu, Qing, Li, Ji-Bin, Ling, Li, Guo, Xiang, Hong, Ming-Huang, Chen, Ming-Yuan

“…Initial 3-year results from our clinical trial in locoregionally advanced nasopharyngeal carcinoma (NPC) patients showed that induction chemotherapy (IC) with…”
Get full text

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial by Cao, Su-Mei, Yang, Qi, Guo, Ling, Mai, Hai-Qiang, Mo, Hao-Yuan, Cao, Ka-Jia, Qian, Chao-Nan, Zhao, Chong, Xiang, Yan-Qun, Zhang, Xiu-Ping, Lin, Zhi-Xiong, Li, Wei-Xiong, Liu, Qing, Qiu, Fang, Sun, Rui, Chen, Qiu-Yan, Huang, Pei-Yu, Luo, Dong-Hua, Hua, Yi-Jun, Wu, Yi-Shan, Lv, Xing, Wang, Lin, Xia, Wei-Xiong, Tang, Lin-Quan, Ye, Yan-Fang, Chen, Ming-Yuan, Guo, Xiang, Hong, Ming-Huang

“…Abstract Background The role of neoadjuvant chemotherapy (NACT) for locoregionally advanced nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the…”
Get full text

Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: More distant metastases and shorter overall survival after treatment by Lv, Xing, Xiang, Yan-Qun, Cao, Su-Mei, Qian, Chao-Nan, Li, Ning-Wei, Guo, Ling, Mai, Hai-Qiang, Chen, Qiu-Yan, Huang, Pei-Yu, Luo, DongHua, Cao, Ka-Jia, Hong, Ming-Huang, Guo, Xiang

“…Background The purpose of this prospective study was to investigate the prognostic value of serum vascular endothelial growth factor (sVEGF) in patients with…”
Get full text

A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma by Qiu, Wen-Ze, Peng, Xing-Si, Xia, Hai-Qun, Huang, Pei-Yu, Guo, Xiang, Cao, Ka-Jia

“…Purpose To compare the clinical outcomes and toxicities of two-dimensional conventional radiotherapy (2D-CRT) and intensity-modulated radiotherapy (IMRT) for…”
Get full text